All Articles in: Boston Scientific
Boston Scientific to Acquire SymetisApril 7, 2017
Company says acquisition demonstrates continued commitment to structural heart portfolio
Approval grants MR-conditional labeling to all EMBLEM S-ICD Systems, further expanding the company’s ImageReady™ portfolio
U.S. FDA Approval for Boston Scientific’s Precision Montage™ MRI Spinal Cord Stimulator SystemMay 20, 2016
Full-Body MRI access expands Spinal Cord Stimulation offering and brings customized therapy to more patients suffering from chronic pain
Boston Scientific Launches Single-Use Flexible UreteroscopeJanuary 12, 2016
Ureteroscopes are used 4600 times a day to examine the urinary tract. Boston Scientific is claiming a first with its new disposable offering, which does sound like a game changer
FDA Approval And CE Mark for Boston Scientific’s DVT CatheterDecember 1, 2015
ZelanteDVT catheter is the first AngioJet catheter designed specifically to treat DVT
Boston Scientific Corporation is to acquire Xlumena, Inc., developer of Endoscopic Ultrasound-guided transluminal drainage devices
Boston Scientific will be hoping its new S-ICD will prove popular based on its advantages over conventionally placed leads
First-Of-Its-Kind alternative to long-term Warfarin therapy for stroke risk reduction in patients with non-valvular atrial fibrillation
Launch and First Implant of Boston Scientific’s Long-Lasting ICDFebruary 3, 2015
The new Extended Longevity ICDs, featuring EnduraLife battery technology promise almost twelve years
Whatever the value of retrospective data, Boston Scientific is touting results that make a solid case for its Precision Spectra spinal cord stimulator system
Boston Scientific SYNERGY™ Bioabsorbable Polymer Stent Meets Key Performance EndpointsNovember 20, 2014
Boston Scientific reports that its SYNERGY™ Everolimus-Eluting Bioabsorbable Polymer Platinum Chromium Coronary Stent System met its primary endpoint in the first successful U.S. pivotal trial of a bioabsorbable polymer stent.
CE Mark for Boston’s Pacemaker Opens MRI Conditionality OptionsOctober 17, 2014
When implanted with Boston Scientific’s INGEVITY™ leads, Boston Scientific’s ACCOLADE pacemakers are the first to enable patients to receive full-body MRI scans in both 1.5 Tesla and 3.0 Tesla systems.
Expert Panel review has culminateded in a vote in favour of Boston Scientific Corporation’s WATCHMAN™ Left Atrial Appendage Closure Device.
Tangled Web Sees ICD Inventor Awarded $309 Million for nowSeptember 26, 2014
The family of the man who helped invent the ICD has been awarded $309 million against Boston Scientific, although appeals loom.
It’s good news/bad news for Boston Scientific’s Vagus Nerve Stimulation plans as a heart failure therapy. While efficacy endpoints suggested no outcome improvement, patients in the treatment group of the sham controlled study reported quality of life improvement.
Sounds like a plan. Combine the offerings of one of the Cardiovascular big boys with wire forming company’s expertise and FFR technology is likely to benefit.
<< Previous Articles